Select Page

Neuroendoscopy Market Overview: 

Neuroendoscopy is known as a minimally-invasive surgical technique that gives neurosurgeons an advantage in removing various tumors through a small hole in the skull. It can be used through mouth or nose as well. removes the tumor through small holes in the skull or through the mouth or nose. The technology provides a scope for various surgeries, which, otherwise, cannot be performed using traditional surgeries. The market for the neuroendoscopy is expecting high growth by 5.2% CAGR during the forecast period of 2017 to 2023. Market research Future (MRFR) makes an assessment of the market and in the report they declared the possibility of surpassing the market by 2023.  

Factors that can play crucial roles in taking the global market for neuroendoscopy forward are growing demand for minimally-invasive surgeries, surge in better technological integration in the market, and others. Apart from these, features like lessening of recovery time, integration of smart gadgets, and others can also improve the market scenario.   

Avail Free Sample @ 

Neuroendoscopy Market Segmentation: 

The market for global Neuroendoscopy, as discussed by MRFR in the study, spans across segments like product, application, usability, and end-user. These segments have details of various factors that can impact the global market in the coming years.  

By products, the neuroendoscopy market would cover rigid neuroendoscopes and flexible neuroendoscopes. The rigid neuroendoscopes segment includes rigid video scopes and rigid fiberscopes. This sub-segmentation would provide advantages in dealing with the regular various details that can impact the market.  

By application, the market for neuroendoscopy comprises intraventricular neuroendoscopytransnasal neuroendoscopy, and transcranial neuro-endoscopy.  

By usability, the segmentation of the neuroendoscopy market includes reusable neuroendoscopes and disposable neur Neuroendoscopy oendoscopes 

By end-users, the neuroendoscopy market encompasses medical research centers, hospitals, clinics, and others. 

Market Regional Analysis: 

The Americas has the better grip over the market as their technological superiority is going to allow them experience better growth. Several other factors are also expected to trigger better growth for the market. Better reimbursement policies, high investment for technologies, various tie-ups and other strategic moves, infrastructural advantage, and others can substantially impact the global market for neuroendoscopy. 

Europe is following the lead of the Americas from a very close quarter. This growth receives much of the traction from countries like the UK, France, Germany, and others. The major reason behind this is the growing awareness regarding minimally invasive surgeries and availability of funding for various research and development teams.  

The APAC market has a lot to contribute as the revamping healthcare sector, inclusion of various technologies, and growing number of patients are impacting the market notably. Various government policies are also expected to provide traction to the market. In addition, the growth in the medical tourism is expected to take the market forward.  

The Middle East and Africa market has the least market share as in the African region a lot of poor economies would hold back the market growth in the coming years. The Middle East, however, would express better possibilities owing to the presence of Dubai, Saudi Arabia, the UAE, Qatar, Kuwait, and others.  

Neuroendoscopy Market Competitive Analysis: 

Numerous companies are taking an active interest in the global neuroendoscopy market and they are solidifying their position in the market by constantly evolving their technologies. MRFR profiled a few in the report to get a feel of how the market is moving ahead and chalking out its future strategies. These companies are Ackermann Instrumente (Germany), Adeor Medical (Germany), KARL STORZ (Germany), B. Braun (Germany), Machida Endoscope (Japan), Hangzhou Hawk Optical Electronic Instruments (China), Tonglu Wanhe Medical Instrument (China), Clarus Medical (U.S.), Schindler Endoskopie (Germany), LocaMed (U.K), Medtronic (U.S.), Olympus Corporation (Japan), Zeiss International (Germany), Visionsense Corporation (U.S.), Stryker (U.S.), and others.  

In an article published in the Lancet in September 2019, researchers revealed a new way of preventing infection in patients who are expected to undergo neuroendoscopy treatments. The treatment would include antibiotics like rifampicin and clindamycin or silver shunts to reduce the cost of the procedure. It would deviate markedly from the standard procedures.  

Browse Complete Report with TOC @